Janux Therapeutics (JANX)Paradigm Biocapital Advisors LP exited its position 2.92M shares

2.92M

Prior-quarter shares · no longer reported

Holdings as of

Dec 31, 2025

Filed

Feb 17, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jan 21, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors

What came next

1. Feb 26, 2026Company filing · Form 8-K · ResultsReported its results
2. Apr 28, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“In order to achieve a more equal balance of membership among the three classes of directors on the Board of Directors (the “Board”) of Janux Therapeutics, Inc. (the “Company”), the Board determined that one of its members should be reclassified from Class III (with a term expiring at the Company’s 2027 Annual Meeting of Stockholders) to Class II (with a term expiring at the Company’s 2026 Annual Meeting of…”
3. May 7, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Janux Therapeutics

For Janux Therapeutics, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JANX page.

How this filing works

• SEC Form 13F

Other disclosures at Janux Therapeutics

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRFeb 17, 2026
• SEC Form 13F-HRNov 14, 2025

Everything OQRO holds on this company is on its JANX page.